{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-094134","form_type":"8-K","ticker":"EDAP","cik":"0001041934","company_name":"EDAP TMS SA","filed_at":"2026-08-11T21:04:53+00:00","discovered_at":"2026-08-11T21:06:00.494485+00:00","generated_at":"2026-08-11T21:06:18.844481+00:00","sec_items":["2.02","8.01","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"FocalTherics reports preliminary Q2 2026 HIFU revenue $12.7-13.2M, up 34-39% YoY; ESWL held for sale","bullets":["Q2 2026 HIFU revenue $12.7M-$13.2M (+34-39% YoY); gross margin 54-56% (+3-5 pts); operating loss ($8.5M)-($7.5M).","ESWL and Distribution segments classified as discontinued operations/held for sale; HIFU reported as continuing operations.","Sold 13 Focal One systems (+44% YoY); installed base 184 (+38 vs Q2'25); U.S. procedure volume +47% YoY.","Cash $21.5M at June 30, 2026; drew €12.0M Tranche B from EIB in April 2026.","Expanding Focal One into BPH (IRB approved in US) and endometriosis (CE mark, FDA Breakthrough, commercial launch at Toulouse)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-094134","json":"https://secwatch.observer/filing/0001104659-26-094134.json","markdown":"https://secwatch.observer/filing/0001104659-26-094134.md","text":"https://secwatch.observer/filing/0001104659-26-094134.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1041934/000110465926094134/0001104659-26-094134-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1041934/000110465926094134/tm2622525d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-11T21:06:18.844481+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}